ADMA Biologics, Inc. (ADMA)
NASDAQ·Healthcare·Biotechnology
$12.98
+1.57%
Mkt Cap $2.56B
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (10 analysts)
$18.67
Range $17.00 – $21.00
Implied Upside
+43.9%
Consensus $18.67 vs current $12.98
NASDAQ·Healthcare·Biotechnology
$12.98
+1.57%
Mkt Cap $2.56B
Buy
1
Hold
1
Sell
0
Price Target (10 analysts)
$18.67
Range $17.00 – $21.00
+43.9%
Consensus $18.67 vs current $12.98